Stericycle, Inc. Q1 2015 NASDAQ: SRCL
Forward - Looking Statements This presentation may contain forward-looking statements that involve a number of risks and uncertainties and our actual results could differ significantly from expected results. Potential risks and uncertainties include difficulties in completing the integration of acquired businesses, changes in governmental regulation of medical waste collection and treatment, and increases in transportation and other operating costs, as well as various other factors described in our public filings with the U.S. Securities and Exchange Commission. Accordingly, past financial performance should not be considered a reliable indicator of future performance, and historical trends should not be used to anticipate future trends or results. For a definition of terms used throughout this presentation please see the last page on our website presentation. 2
Stericycle Overview A global business-to-business solutions provider Specializing in complex and highly regulated arenas Regulated Waste Management & Compliance Solutions Brand Protection Services Environmental & Sustainable Solutions Patient & Customer Communications Solutions Supporting healthcare and commercial organizations big and small 3
Broad Range of High Quality Services Regulated and Compliance Solutions Medical Waste Services Compliance Programs Sharps Management Service Pharmaceutical Waste Disposal Hazardous Waste Services Communication Solutions Recall and Returns Management Solutions Notification, Communication, Retrieval, Disposal & Compliance 4
Market Leadership Total Estimated Global Market Size: $19.5 billion* Onsite Management and Other Competitors 87% Stericycle 13% Note: Includes global markets with established regulatory framework for medical waste plus global markets in which Stericycle operates for recall/returns, hazardous waste and communication services. Source: Various industry studies and management estimates (including ancillary services & products). 5
Loyal Customer Base Highly regulated industry U.S. Market: EPA, DEA, FDA, OSHA, DOT, State/Local; International markets have similar agencies Insulated from economic cycles Diverse customer base with largest customer counting for less than 2% of revenues Hospitals, medical and dental offices, offsite and alternate care providers, pharmaceutical manufacturers, biomedical/biotech companies, laboratories, pharmacies, corporate sites, retailers, universities, municipalities, and manufacturers Predictable revenues: over 95% of revenues are under long term contracts Contracts generally include pass through price increase provisions 6
Growth Strategy Acquisitions Enhance Service Platforms International Expansion Leverage Customer Relationship 7
Focus on Small Customers Small account customers generate gross margins higher than large account customers Small account customers are more likely to outsource and are easier to up-sell 1996 % Revenue Mix* Q1-2015 Small Account Customers 33% Large Account Customers 67% Small Account Customers 63% Large Account Customers 37% 21.0% Gross Margin 42.4% Gross Margin *Note: Domestic SQ and LQ revenue mix 8
Medical Waste Services Compliant management of medical waste to protect workers, reduce cross contamination risk, and improve sustainability Necessary regulated services Large diverse customer base Worldwide market opportunity Foundation for a portfolio of regulated waste and compliance services Low cost operator Attractive margins 9
Compliance Solutions Promotes safety, compliance, and best practices for healthcare employees - Steri-Safe OSHA & HIPAA - Clinical Services (International) - Medical & Pharmaceutical Waste Subscription compliance resources Significant up-sell opportunities International expansion MyStericycle.com Clinical Services Consulting Services 10
Sharps Management Service Provides a safer workplace by reducing the infection risk from inadvertent needle sticks and supports sustainability efforts Turnkey integrated sharps safety solution to manage & collect reusable sharps containers Synergy with existing transportation and treatment Infrastructure International expansion opportunities 11
Pharmaceutical Waste Disposal Protects the environment through proper handling, segregation, transportation and disposal of pharmaceutical waste Turnkey integrated pharmaceutical waste management system for healthcare Synergy with existing infrastructure 12
Hazardous Waste Management Services Minimizes environment impact with the proper segregation, transportation and disposal of a wide variety of hazardous materials Turnkey solutions for the retail and healthcare industry Creative solutions to support corporate sustainability goals Leverages logistics and waste management expertise 13
Network of Premier Waste Management Assets Integrated Network Global Presence Collection/Transfer Processing/TSDF 14
Communication Solutions Live voice telephone answering service, automated appointment reminders, appointment scheduling, physician referrals, post discharge and wellness calls Essential service for current customer base Serving medical offices, clinics, community care centers, hospitals, and commercial businesses Leverages recall call center expertise 15
LQ/SQ Opportunity LQ Hospital Example SQ Physician Practice Example Communication Solutions Haz Waste Sharps Management Med Waste Revenue Range $75k - $100k $10k - $15k Rx Waste $35k - $40k $35k - $40k $30k - $35k Communication Solutions Secure Messaging Automated Reminder After Hours Daytime Call Management Compliance Rx Waste Med Waste Revenue Range $6.3k - $8.8k $1.2k - $1.5k $1.5k - $1.8k $1.0k - $1.5k Total Revenue Opportunity: $185k - $230k 6X Med Waste Revenue Total Revenue Opportunity: $10k - $13.6k 10X Med Waste Revenue 16
Recall and Returns Management Solutions Comprehensive notification, returns or recall, and call center solutions to protect and build brands Reduces business and consumer risk Serving manufactures of all types, hospitals, distributors, and retail pharmacies Growing capability in global markets 17
Acquisitions Proven integrator having successfully completed 407 acquisitions since 1993 Current worldwide acquisition pool represents more than $100 million in revenues Purchase price is based on IRR/multiples of EBITDA and depends on the risk and quality of the assets purchased 18
Proven Financial Performance CAGR 15.9% Revenue $324 $359 $402 $453 $516 $610 $790 $933 $1,084 $1,178 $1,439 $1,676 $1,913 $2,143 $2,556 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 CAGR Non-GAAP EBIT 16.2% EBIT (non-gaap) $75 $88 $104 $126 $147 $167 $202 $240 $280 $325 $391 $444 $499 $557 $615 GAAP EBIT 2000 $63 2001 $73 2002 $101 2003 $126 2004 $146 2005 $167 2006 $202 2007 $225 2008 $274 2009 $315 2010 $371 2011 $424 2012 $469 2013 $536 2014 $556 CAGR Non-GAAP EPS 20.9% EPS (non-gaap) $0.30 $0.37 $0.54 $0.73 $0.88 $1.04 $1.16 $1.42 $1.73 $2.09 $2.52 $2.85 $3.30 $3.75 $4.27 GAAP EPS 2000 $0.18 2001 $0.17 2002 $0.51 2003 $0.71 2004 $0.85 2005 $0.74 2006 $1.16 2007 $1.32 2008 $1.68 2009 $2.03 2010 $2.39 2011 $2.69 2012 $3.08 2013 $3.56 2014 $3.79 19
Capitalization ($ in millions) Dec 31, 2013 Dec 31, 2014 Mar 31, 2015 Current Portion of Long Term Debt $150.4 $132.0 $113.2 Revolver / Term Loan $272.4 $460.0 $425.6 Private Placement $750.0 $750.0 $750.0 Other Debt $258.3 $317.3 $286.6 Total Long Term Debt $1,280.7 $1,527.3 $1,462.2 Common Equity* $1,750.5 $1,895.0 $1,930.9 Total Capitalization $3,181.5 $3,554.2 $3,506.3 Debt to EBITDA 2.06X 2.22X 2.07X * Common Equity is defined as Total Shareholders Equity less noncontrolling interests. 20
Investment Highlights Attractive broad range of niche services Emerging global market Low cost provider Diverse customer base Strong financial performance and strong free cash flow Demonstrated growth strategy Successful in integrating acquisitions and improve margins Proven, experienced, worldwide management team 21
Appendix Stericycle, Inc. NASDAQ: SRCL
Financial Footnotes EBIT NOTES 2000-2001: Adjusted for pro-forma adoption of new accounting standards to cease amortization of goodwill. 2006-2015: Includes expensing of stock compensation. 2000-2015: Excludes integration related costs, write-off of fixed assets and other non-operational items. 2009-2015: Excludes expenses associated with acquisitions/business combinations. EPS NOTES Adjusted for 2-for-1 stock split in May 2002 and in May 2007. Non-GAAP EPS is adjusted for: Acquisition and integration related costs, bond buyback premium & bank loan financing fees, tax adjustment to fully taxed, noncash fixed assets write-offs, legal settlements, non-cash write-down of investments, goodwill amortization pre-2002, insurance proceeds, note receivable write-down, gain on divestiture of assets, impairment of intangible assets, restructuring and litigation costs. Expensing of stock compensation is NOT part of the adjustments. 23
Definition of Terms This presentation uses certain abbreviations: CAGR means compound annual growth rate EBIT means earnings before interest expense and income taxes EPS means earnings per share diluted GAAP means United States generally accepted accounting principles LQ refers to a Large Account customer SQ refers to a Small Account customer Free Cash Flow means cash from operations less capital expenditures 24